| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.3 | 0.05 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.39 | 0.05 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |